We are live on ! Find out more
BWLSA

Blue Water Life Science Advisors Portfolio holdings

AUM $159M
1-Year Est. Return 139.66%
This Fund
S&P 500
This Quarter Est. Return
-6.03%
1 Year Est. Return
+139.66%
3 Year Est. Return
+503.09%
5 Year Est. Return
+228.74%
10 Year Est. Return
–
AUM
$327M
AUM Growth
+$19.5M
Cap. Flow
+$40.6M
Cap. Flow %
12.42%
Top 10 Hldgs %
98.06%
Holding
29
New
5
Increased
2
Reduced
1
Closed
16

Top Buys

Rank Stock Value
1
GH icon
Guardant Health
GH
+$27.3M
2
AKYA
Akoya BioSciences
AKYA
+$22.4M
3
NTRA icon
Natera
NTRA
+$17.5M
4
AVTR icon
Avantor
AVTR
+$16.2M
5
DHR icon
Danaher
DHR
+$9.76M

Top Sells

Rank Stock Value
1
RVTY icon
Revvity
RVTY
+$19.6M
2
TWST icon
Twist Bioscience
TWST
+$13.4M
3
NEO icon
NeoGenomics
NEO
+$10.7M
4
CDNA icon
CareDx
CDNA
+$3.94M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$815K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
2 Communication Services 0%
3 Consumer Discretionary 0%
4 Energy 0%
5 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RVTY icon
26
Revvity
RVTY
$13.3B
– –
-112,850
Closed -$19.6M
SYK icon
27
Stryker
SYK
$130B
– –
-1,800
Closed -$475K
TWST icon
28
Twist Bioscience
TWST
$8.93B
– –
-125,175
Closed -$13.4M
V icon
29
Visa
V
$682B
– –
-1,809
Closed -$403K
1
2

Similar funds

SFC
Swisher Financial Concepts Westerville, Ohio $159M AUM 23.09% 1-Year Est. Return
ACP
Argyle Capital Partners Los Angeles, California $159M AUM 21.07% 1-Year Est. Return
CW
Cooksen Wealth The Woodlands, Texas $159M AUM 23.21% 1-Year Est. Return
SG
Stanich Group Montauk, New York $159M AUM 24.04% 1-Year Est. Return
LA
Lakeside Advisors Seattle, Washington $159M AUM 11.13% 1-Year Est. Return
CMMS
Comprehensive Money Management Services Coral Gables, Florida $159M AUM 18.94% 1-Year Est. Return
JWM
JP Wealth Management Mt. Pleasant, South Carolina $159M AUM 19.83% 1-Year Est. Return
AC
Agman Capital Omaha, Nebraska $159M AUM

Blue Water Life Science Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Blue Water Life Science Advisors held 29 positions worth $327M, up 6.3% from $307M the previous quarter. Its ten largest holdings account for 98% of the portfolio.

Blue Water Life Science Advisors deployed $40.6M of net new capital in Q4 2021, opening 5 new positions and adding to 2 existing holdings. Its largest new stake was Akoya BioSciences: 1,710,807 shares worth $26.2M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 98% a quarter earlier, followed by Communication Services and Consumer Discretionary.

On the sell side, the largest reduction was CareDx, an estimated $3.94M trimmed.

  • Blue Water Life Science Advisors's largest Q4 2021 buy was Akoya BioSciences: 1,710,807 shares worth $26.2M.
  • Blue Water Life Science Advisors added most to Guardant Health in Q4 2021, an estimated $27.3M increase.
  • Blue Water Life Science Advisors's biggest Q4 2021 reduction was CareDx, cutting an estimated $3.94M.
  • Blue Water Life Science Advisors fully exited Revvity in Q4 2021, selling an estimated $19.6M.
  • Blue Water Life Science Advisors's ten largest holdings make up 98% of its $327M portfolio in Q4 2021.
  • Blue Water Life Science Advisors opened 5 new positions and closed 16 in Q4 2021.
  • Blue Water Life Science Advisors's portfolio value rose 6.3% quarter-over-quarter to $327M.

Based on Blue Water Life Science Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.